U.S. Hospitality Stock News

AAR CORP. recently launched Airvoyant, an AI-powered aviation procurement platform that integrates with Aeroxchange’s supplier network and airline ERP systems, with early collaboration from carriers including Delta Air Lines and Air Canada. This move signals AAR’s push to embed data-driven technology more deeply into aviation supply chains, potentially reshaping how airlines and MROs source critical parts and manage inventory. Next, we’ll examine how Airvoyant’s AI-driven procurement...

Old Republic International recently launched Lodestar Claims & Risk Services Inc. as an independent brand and standalone operating company within its organization, separating the long-standing third-party administrator business from PMA Companies while keeping leadership, operations, and client teams unchanged. This move gives Old Republic’s top-10 national TPA a distinct market identity, potentially sharpening its competitive positioning and helping deepen relationships with large...

Capri Sun, part of Kraft Heinz, has launched Capri Sun Hydrate, a kids’ electrolyte drink, with a national retail rollout in the US. Kraft Heinz is pairing this with large scale NFL Draft marketing, including its long running "Mr. 57" activation and citywide advertising tied to its global NFL partnership. These moves extend Kraft Heinz beyond core pantry staples into children’s hydration and higher profile sports based brand engagement. Kraft Heinz (NasdaqGS:KHC) is making these moves...

Legend Biotech has reported its 2025 full-year results, highlighting the ongoing commercial traction of its multiple myeloma therapy CARVYKTI and surpassing a cumulative 10,000 patients treated to date. The expansion of its Raritan site into the largest cell therapy manufacturing facility in the US, with capacity for 10,000 patients annually, underscores Legend’s push to industrialize CAR-T production at scale. Next, we’ll examine how scaling CARVYKTI manufacturing capacity to 10,000...

Bath & Body Works (NYSE:BBWI) is rolling out a companywide "Consumer First Formula" plan that combines store closures, cost savings and new digital initiatives. The retailer is closing more than 90 stores and reworking its physical footprint with less emphasis on traditional malls. As part of the shift, Bath & Body Works is expanding its online reach with curated product sales on Amazon. For investors watching NYSE:BBWI, the new plan comes after a mixed stretch for the stock. Shares...

The Bank of New York Mellon Corporation ( NYSE:BK ) is about to trade ex-dividend in the next four days. The...

If you are wondering whether Rayonier's share price reflects its real worth, the recent moves give you plenty to think about before making your next decision. The stock has slipped 0.4% over the last 7 days, but is up 8.7% over 30 days while still showing a 1.9% decline year to date and a 5.4% decline over the last year, with 3 year and 5 year returns of 14.0% and 19.8% declines respectively. These mixed returns have kept attention on how Rayonier is positioned within the Specialized REITs...

In April 2026, Pacira BioSciences filed a preliminary proxy urging shareholders to support its three board nominees over those put forward by DOMA Perpetual Capital Management, while also presenting new real-world data at a major managed care pharmacy meeting showing EXPAREL’s economic and opioid-sparing profile in outpatient hip and knee replacements. The combination of proxy contest developments and fresh health-economic evidence for EXPAREL’s use in high-volume joint procedures sharpens...

If you are wondering whether Travere Therapeutics at around US$38.78 is priced attractively or already reflects the story, the next sections focus squarely on what you are getting for that price. The stock has been volatile recently, with a 44.5% gain over the last 30 days, a 144.2% return over the past year, and a small 1.9% decline year to date, which can change how investors think about both upside and risk. Recent news coverage has focused on Travere Therapeutics as a biotechnology name...

Wondering if Circle Internet Group at around US$96.02 is starting to look expensive or still has room to run? This breakdown is designed to help you weigh that up with clear valuation checks. The stock has had a mixed run recently, with a 9.0% decline over the past week and a 23.8% decline over the past month, even though it remains up 15.0% year to date. Recent attention on Circle Internet Group has focused on its position in the software sector and how investors are reassessing growth...

In April 2026, Hamilton Insurance Group, Ltd. announced it had established a multi-year casualty reinsurance sidecar with investor capital from Sixth Street, targeting approximately US$300 million in ceded premium and delivered through its third-party capital platform, Ada Re, Ltd. This move deepens Hamilton’s use of third-party capital via Ada Re, which is becoming an increasingly important contributor to its fee-based earnings and broadens the solutions offered alongside its Bermuda-based...

Why WesBanco is on investors’ radar this month WesBanco (WSBC) has drawn fresh attention after recent share price moves, with the stock showing a month gain alongside a modest pullback over the past week and day. That mix often prompts investors to reassess fundamentals. See our latest analysis for WesBanco. Viewed over a longer stretch, WesBanco’s recent pullback sits against a stronger backdrop, with a 30 day share price return of 7.9% and a 1 year total shareholder return of 29.1%, which...

Hims & Hers Health (HIMS) is back in focus after renewing its partnership with Novo Nordisk, giving the telehealth platform access to branded weight loss drugs as FDA peptide policy changes reshape the GLP 1 market. See our latest analysis for Hims & Hers Health. After a sharp run that produced a 39.33% 7 day share price return and a 35.15% 30 day share price return, Hims & Hers is giving back some ground. The latest 4.03% single day share price decline reflects investors reassessing...

Williams Companies (WMB) is back on investors’ radar after recent trading pulled the stock further off its past 3 month highs, despite a solid 1 year total return and sizeable US$11.8b revenue base. See our latest analysis for Williams Companies. The recent cooling in the share price, with a 1 month share price return showing a 2.73% decline after a strong 90 day gain of 11.48%, comes against a much stronger backdrop highlighted by a 1 year total shareholder return of 24.98% and a very large...

Magnite (NasdaqGS:MGNI) has been selected as a preferred deal partner by Hearst News. The expanded collaboration focuses on delivering new video ad formats across web and connected TV. The partnership deepens the integration between Magnite and its SpringServe ad-serving platform for Hearst News inventory. For investors following Magnite, this update sits at the core of its supply side ad tech business, which connects publishers and advertisers across video, display, and CTV. Hearst News...

If you are wondering whether Lincoln National's recent share price reflects fair value or a possible mismatch, this article walks through what the current numbers can and cannot tell you about the stock. At a last close of US$36.69, the share price sits against a mixed return profile, with gains of 3.8% over 7 days and 8.5% over 30 days, set alongside a 1 year return of 26.9%, a 3 year return of 113.2%, a 5 year return representing a 26.8% decline, and a year to date return representing an...

Adient stock snapshot after recent moves Adient (ADNT) shares have shifted in recent trading, leaving investors weighing how current pricing near $21.88, recent monthly gains, and past 3 months softness line up with the company’s latest financial profile. See our latest analysis for Adient. Recent trading has been choppy, with a 6.58% 7 day share price return and an 11.75% 30 day share price return, set against a slightly negative 90 day share price return and a much stronger 82.18% 1 year...

In mid-April 2026, S&P Global expanded its physical and intellectual footprint by inaugurating a new state-of-the-art office in Downtown Gurugram and participating in the Jakarta Energy Briefing 2026, while also advancing a knowledge partnership between S&P Global Energy and the UN Sustainable Stock Exchanges to support energy transition in capital markets. These moves highlight how S&P Global is deepening its role as a core data and analytics provider for energy transition and...

Earlier this year, Marriott Vacations Worldwide completed a US$460 million securitization of vacation ownership loans through MVW 2026-1 LLC, with the notes sold to qualified institutional buyers in the US and internationally. The company plans to use the proceeds to pay down its credit facility and for general corporate purposes, potentially reshaping its balance sheet flexibility ahead of its upcoming first-quarter 2026 results discussion. Next, we'll examine how this US$460 million...

Earlier in April 2026, BioNTech reported positive Phase 2 data for its HER2-targeted antibody-drug conjugate trastuzumab pamirtecan in previously treated advanced endometrial cancer, showing clinically meaningful responses across all HER2 expression levels with a manageable safety profile. The results, together with Fast Track and Breakthrough Therapy designations and plans for a 2026 biologics license application, highlight how this program could support BioNTech’s broader shift toward...

Nuvation Bio (NYSE: NUVB) reported new long term follow up data for IBTROZI (taletrectinib) in advanced ROS1 positive non small cell lung cancer, showing durable responses and strong intracranial activity. The company also expanded its global rights to safusidenib, now including Japan, supporting the launch of pivotal trials there. These updates come alongside an ongoing focus on building out Nuvation Bio's oncology franchise. Nuvation Bio enters this news cycle with shares at $5.11 and a...

Why Franklin Resources Is On Investor Radar Today Franklin Resources (BEN) has quietly put up a 59.55% total return over the past year, putting fresh attention on how its current US$27.24 share price lines up with recent fundamentals. See our latest analysis for Franklin Resources. The recent 16.11% 1‑month share price return and 14.45% year‑to‑date share price return, capped by a 59.55% 1‑year total shareholder return, suggest momentum has been building as investors reassess Franklin...

RLI stock in focus RLI (RLI) is back on investor radars after recent trading left the shares around $58.40, with one day and one week returns just under 1%, and year to date performance weaker. See our latest analysis for RLI. The recent 1 day and 7 day share price returns of around 1% sit against a weaker year to date share price return of 6.5% and a 1 year total shareholder return of 22.2%. This suggests momentum has cooled after earlier long term gains. If you are weighing RLI against...

If you are wondering whether Kimco Realty at around US$23.69 is priced attractively or already baking in a lot of optimism, the starting point is to look closely at what you are actually paying for. The stock has returned 0.4% over the last 7 days, 6.0% over 30 days, 18.1% year to date, 21.4% over 1 year, 45.2% over 3 years and 41.7% over 5 years, so recent price action gives you some useful context before thinking about value. Recent headlines around Kimco Realty have focused on its...